Cosmo Pharmaceuticals NV (CHIX:COPNZ) Price-to-Tangible-Book : 29.50 (As of May. 12, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Cosmo Pharmaceuticals NV Price-to-Tangible-Book?

As of today (2024-05-12), Cosmo Pharmaceuticals NV's share price is CHF70.50. Cosmo Pharmaceuticals NV's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was CHF2.39. Hence, Cosmo Pharmaceuticals NV's Price to Tangible Book Ratio of today is 29.50.

The historical rank and industry rank for Cosmo Pharmaceuticals NV's Price-to-Tangible-Book or its related term are showing as below:

CHIX:COPNz' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.84 Med: 5.15 Max: 29.62
Current: 29.62

During the past 13 years, Cosmo Pharmaceuticals NV's highest Price to Tangible Book Ratio was 29.62. The lowest was 2.84. And the median was 5.15.

CHIX:COPNz's Price-to-Tangible-Book is ranked worse than
96.44% of 871 companies
in the Drug Manufacturers industry
Industry Median: 2.41 vs CHIX:COPNz: 29.62

A closely related ratio is called PB Ratio. As of today, Cosmo Pharmaceuticals NV's share price is CHF70.50. Cosmo Pharmaceuticals NV's Book Value per Sharefor the quarter that ended in Jun. 2023 was CHF26.17. Hence, Cosmo Pharmaceuticals NV's P/B Ratio of today is 2.69.

Cosmo Pharmaceuticals NV Price-to-Tangible-Book Historical Data

The historical data trend for Cosmo Pharmaceuticals NV's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cosmo Pharmaceuticals NV Price-to-Tangible-Book Chart

Cosmo Pharmaceuticals NV Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.84

3.00

3.03

9.61

15.41

Cosmo Pharmaceuticals NV Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															3.28	9.61	10.52	15.41	19.04

Competitive Comparison of Cosmo Pharmaceuticals NV's Price-to-Tangible-Book

For the Drug Manufacturers - General subindustry, Cosmo Pharmaceuticals NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cosmo Pharmaceuticals NV's Price-to-Tangible-Book Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cosmo Pharmaceuticals NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Cosmo Pharmaceuticals NV's Price-to-Tangible-Book falls into.

Cosmo Pharmaceuticals NV Price-to-Tangible-Book Calculation

Cosmo Pharmaceuticals NV's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	70.50	/	2.39
	=	29.50

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Cosmo Pharmaceuticals NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Cosmo Pharmaceuticals NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cosmo Pharmaceuticals NV (CHIX:COPNz) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

CMOPF:USA C43:Germany COPN:Switzerland

Address

Sir John Rogerson’s Quay, Riverside II, Dublin, IRL, 2

Website

https://www.cosmopharma.com

Cosmo Pharmaceuticals NV is a pharmaceutical company with a focus on gastrointestinal diseases, dermatology and healthtech. The company develops and manufactures products that are distributed globally by its partners. Products that the company has developed include Lialda/Mezavant/Mesavancol and Uceris/Cortiment, for the treatment of ulcerative colitis; GI Genius, which uses artificial intelligence to aid the detection of colorectal polyps during colonoscopy; Eleview, a submucosal injectable composition for use in gastrointestinal endoscopic procedures; Aemcolo for the treatment of travellers' diarrhoea (TD) and Winlevi for the treatment of acne. Product pipeline includes Breezula, GI Genius, Methylene blue MMX, Aemcolo, CB-03-10 and CB-01-33.

Cosmo Pharmaceuticals NV (CHIX:COPNZ) Headlines

No Headlines